Skip to main content

Therapeutics Startups

Updated July 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,708
Total Funding
$1.3B
Avg Funding
$51.4M
Global Reach
4
countries

Top Cities for Therapeutics

Cambridge
Lexington
New York
San Francisco
Chicago
Perugia

Recently Funded Companies

Export
Cambridge, United States

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

$60.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Lexington, United States

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

$140.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

New York, United States

ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

Jan 2022

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Echo Neurotechnologies specializes in brain-machine interfaces that provide patients control over external gadgets.

$50.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Chicago, United States

NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better.

$34.0M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Perugia, Italy

Corabea is a healthcare and wellness company that provides clinical care and digital tools for patients dealing with eating disorders.

$772K raised
Jan 2026

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.

$2.9M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Phoenix, United States

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

$60.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Bethesda, United States

Aradigm Health platform enables access to next generation of transformative therapies—cell and gene therapies (CGTs).

$20.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

$350.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

New York, United States

Parallel is a provider of learning assessments and treatment solutions for students with learning and thinking differences.

$20.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Philadelphia, United States

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

$29.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Princeton, United States

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

$3.9M raised
Dec 2024

Founder Contacts

30,000+ verified contacts

Phoenix, United States

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

$50.0M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Denver, United States

Goally is a software-driven behavior therapy for children with ADHD or autism.

$2.3M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

$257.0M raised
Jan 2026

Founder Contacts

30,000+ verified contacts

Woburn, United States

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

$110.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Rotterdam, The Netherlands

Pan Cancer T is a biotechnology company that develops T‑cell receptor T‑cell therapies to treat solid tumors.

$5.8M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Atlanta, United States

Parallel cultivates, produces, and processes cannabis for medical purposes.

$10.0M raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Gaithersburg, United States

Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.

$15.0M raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Cleveland, United States

Convelo Therapeutics specializes in developing medicines to regenerate myelin around nerve cells and restore function

$10.8M raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Basel, Switzerland

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

$537K raised
Jan 2022

Founder Contacts

30,000+ verified contacts

Astoria, United States

Enable My Child is a high-quality solution in pediatric mental health, speech, physical, and occupational therapy leveraging AI.

$7.7M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Seattle, United States

Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery.

$5.0M raised
Dec 2022

Founder Contacts

30,000+ verified contacts

New Haven, United States

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

$40.0M raised
Jan 2022

Founder Contacts

30,000+ verified contacts

Showing 1276 to 1300 of 1,708 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.

Average Funding
$51.4M
Total Funding Tracked
$1.3B
Countries Represented
4

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.New York
2 companies$20.0M
2.Phoenix
2 companies$110.0M
3.Cambridge
1 companies$60.0M
4.Lexington
1 companies$140.0M
5.San Francisco
1 companies$50.0M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked